Home | Recon4IMD

Reconstruction and Computational Modelling for Inherited Metabolic Diseases

Accelerating the diagnosis and personalising the management

of inherited metabolic diseases.

ReconMap33.33_withoutColor_fisheye_glycolysis_2small.jpeg

Key features of Recon4IMD

Overall objectives: Accelerate diagnosis and personalise management of inherited metabolic diseases.
Primary output: Clinically validated decision support tools enabling accelerated diagnosis and personalised management of inherited metabolic diseases, based on genomic, proteomic, and metabolomic data-driven computational models.
Sustainability: Development of academic technology to meet medical regulatory standards and a roadmap for exploitation within a European foundation to aid personalised diagnosis and management of inherited metabolic diseases.
Implemented by: A group of world-class scientists and clinicians from a diversity of disciplines who have collaborated multiple times and have a track record of leading key national and EU-funded initiatives to deliver high-impact results.

News & Events

We are hiring!

Click for more

Have a regular look at our job opening section as we are actively hiring potential candidates.

If you are interested, additionally you can send in your resume to recruit.recon4imd(@)gmail.com

U-IMD Support channel

U-IMD is the acronym for the Unified European Registry for Inherited Metabolic Disorders. The overall aim of this project is to promote health for children, adolescents and adults affected by rare Inherited Metabolic Disorders (IMDs)

Click for more

Latest Publications

Integration of proteomics with genomics and transcriptomics increases the diagnostic rate of Mendelian disorders

Here, we demonstrate the effectiveness of combining genomics, transcriptomics, and, for the first time, proteomics and phenotypic descriptors, in a systematic diagnostic approach to discover the genetic cause of mitochondrial diseases.